Cleveland Clinic-led Study Finds That New Blood Test is More Accurate in Predicting Overall Risk of Prostate Cancer than Standard Prostate-Specific Antigen (PSA)
A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures – distinguishing cancer from benign conditions, and identifying patients with high-risk disease.
ERT Acquires Imaging Solution from Cleveland Clinic
ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced the acquisition of ImageIQ, originally established as Cleveland Clinic’s Biomedical Imaging and Analysis Center. The acquisition enables ERT to offer advanced, end-to-end clinical trial imaging analysis using best-in-class technology that delivers compliant data for use in clinical development.
Cleveland Clinic spinoff that makes head impact monitoring technology raises $6 million in new financing
Prevent Biometrics, a Cleveland Clinic spinoff based in suburban Minneapolis that makes head impact monitoring technology, announced it has raised $6 million in new financing.
A Cleveland Clinic spinoff is trying to get ahead with a mouth guard that helps detect concussions
A Cleveland Clinic spinoff based in suburban Minneapolis is raising money to continue to develop a head impact-monitoring mouth guard that aims to reduce undetected concussions.
Surgical startup poised to enter market
Cleveland-based surgical navigation startup Centerline Biomedical Inc. is gearing up to enter the market in 2017 with its GPS-like system that provides 3-D guidance during endovascular surgery.